Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Followup
- Conditions
- Peripheral Arterial Disease
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2022-10-21
- Lead Sponsor
- Taryag Medical Ltd.
- Target Recruit Count
- 75
- Registration Number
- NCT05110079
- Locations
- 🇩🇪
Karolinen-Hospital, Klinik für Angiologie, Arnsberg, Germany
🇩🇪Universitätsklinikum Heidelberg, Heidelberg, Germany
🇩🇪Bonifatius Hospital Lingen, Lingen, Germany
Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm
Not Applicable
Completed
- Conditions
- Arterial Occlusive Diseases
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2020-04-14
- Lead Sponsor
- Taryag Medical Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT03724279
- Locations
- 🇩🇪
Augusta-Krankenhaus, Dusseldorf, Germany
🇩🇪Bonifatius Hospital Lingen, Lingen, Germany
News
No news found